PAR-21-128 - The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer |
NOT-CA-23-018 |
NCI
|
Jan 19, 2023 |
Sep 8, 2024
|
K01, R01, K22, K08, R21, U34, K99/R00, P01, R34 |
Notice of Special Interest (NOSI): Career Development Opportunities for Research Within the Mission of the Division of Cancer Prevention at the National Cancer Institute |
NOT-CA-23-035 |
NCI
|
Jan 18, 2023 |
Nov 13, 2024
|
K22, K08, K99/R00, K01 |
Notice of Special Interest (NOSI): Adaptive Biomaterials for Cancer Biology |
NOT-CA-23-030 |
NCI
|
Jan 10, 2023 |
May 7, 2025
|
R01, K22, K99/R00 |
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer |
NOT-CA-22-085 |
NCI
|
May 5, 2022 |
Jul 5, 2027
|
K22, R01, K08, K01, R21, R03, K99/R00 |
Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy |
NOT-CA-22-063 |
NCI , NIAID , NIAMS , NIDCR
|
May 3, 2022 |
Jul 5, 2024
|
R01, R21, K99/R00, K01, K08, K22, R03, R15 |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
|